215
Participants
Start Date
January 31, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
March 31, 2010
Risperidone
Continued treatment with the medication risperidone for schizophrenia for up to 6 months in study
Olanzapine
Continued treatment with the medication olanzapine for schizophrenia for up to 6 months in study
Quetiapine
Continued treatment with the medication quetiapine for schizophrenia for up to 6 months in study
Aripiprazole
Switching medication to aripiprazole for schizophrenia for up to 6 months in study
Research Foundation for Mental Hygiene, New York
University of Rochester, Rochester
Philadelphia VA Medical Center-116A, Philadelphia
Clinical Insights, Glen Burnie
John Umstead Hospital/Duke University, Butner
Carolinas HealthCare System, Charlotte
Emory University, Atlanta
Medical College of Georgia, Augusta
University of Miami School of Medicine, Miami
Mental Health Advocates, Boca Raton
University of Cincinnati, Cincinnati
Wayne State University, Detroit
University of Iowa, Iowa City
University of Minnesota, Minneapolis
Washington University School of Medicine, St Louis
Clinical Research Institute, Wichita
Lousiana State University Health Sciences Center, Shreveport
University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine, Houston
University of Texas Health Science Center at San Antonio, San Antonio
New Mexico VA Healthcare System, Albuquerque
SHANTI Clinical Trials, Colton
Stanford University, Palo Alto
Yale University, New Haven
Freedom Trail Clinic, Boston
John C Corrigan Community Mental Health Center, Fall River
University of Massachusetts, Worcester
The University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH)
NIH